Medical Devices Investors & VC Firms in Germany

97 firms in this list, with a median first check of $540K. 30 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
NO Novalis Biotech JVWVKMJB9 people	88🔒	Ghent	BE	Pre-Seed–Series A	—	+ Add to CRM
KO Korea Investment Partners DJJHJHMS17 people	88🔒	Seoul	KR	Seed–Late Stage	$973K – $50M	+ Add to CRM
PA PAI Partners AAAAEAEA8 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
GE GENIUS Venture Capital UBIJRFMS4 people · Leads rounds	88🔒	Schwerin	DE	Pre-Seed–Series A	$540K – $1.6M	+ Add to CRM
AE Aescap Life Sciences PKPDBJGH14 people	88🔒	Amsterdam	NL	Seed–Growth	—	+ Add to CRM
DE DeepTech & Climate Fonds RSAPSS3 people · Leads rounds	88🔒	Munich	DE	Seed–Late Stage	$5.5M – $55M	+ Add to CRM
FR Fresenius Medical Care Ventures AWAWASBH8 people	88🔒	Bad Homburg	DE	Seed–Late Stage	—	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLCW12 people	88🔒	Contern	LU	Seed–Late Stage	$10.8M	+ Add to CRM
YZ YZR Capital MFPDDMHE6 people · Leads rounds	88🔒	Munich	DE	Pre-Seed–Growth	—	+ Add to CRM
SI Sirius Venture Partners GmbH FVMBASJS8 people	88🔒	Wiesbaden	DE	Seed–Growth	$540K – $5.4M	+ Add to CRM
YZ YZR Capital MFRMHEMS11 people	88🔒	Munich	DE	Pre-Seed–Growth	—	+ Add to CRM
LI Linden Capital	88🔒	Chicago	DE	Pre-Seed–Series A	—	+ Add to CRM
M M ACCELERATOR AMSHACAP6 people · Follows rounds	88🔒	Los Angeles	MX	Growth	$1M – $5M	+ Add to CRM
NO Nordic Capital KMCHHJJS7 people · Leads rounds	88🔒	Copenhagen	DK	Growth–Late Stage	—	+ Add to CRM
TA Tauros Capital BPCNMW3 people	88🔒	Vienna	AT	Series A–Growth	$2.2M	+ Add to CRM
ED EDB Investments CKCLCGJO11 people	88🔒	Singapore	SG	Seed–Late Stage	$12M – $400M	+ Add to CRM
P5 P53 Invest SSLMKSØS5 people	88🔒	Stavanger	NO	Seed–Series A	—	+ Add to CRM
CA Catalpa Ventures CGNWSRTG5 people · Leads rounds	88🔒	Grevenmacher	LU	Pre-Seed–Series A	$330K – $1.6M	+ Add to CRM
TA Target Partners BVKMKMWJ10 people	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $3.2M	+ Add to CRM
CA Castel Capital ACJHMLPV4 people · Follows rounds	88🔒	Paphos	CY	Seed–Growth	$100K – $1M	+ Add to CRM
RO Rosetta Capital Ltd. JHKMMFDL7 people	88🔒	Oxford	GB	Series A–Late Stage	—	+ Add to CRM
HT HTGF RSAVDA3 people · Follows rounds	88🔒	Bonn	DE	Pre-Seed–Series A	$1.1M	+ Add to CRM
VE Ventura BioMed Investors AJKR2 people · Follows rounds	88🔒	Munich	DE	Seed–Series A	$1.1M – $5.5M	+ Add to CRM
NG NGN Capital JCKAPJKJ6 people	88🔒	New York	US	Series A–Late Stage	—	+ Add to CRM

Novalis Biotech

GhentPre-Seed–Series A

JVWVKMJB9 people

Korea Investment Partners

SeoulSeed–Late Stage$973K – $50M

DJJHJHMS17 people

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAAAEAEA8 people

GENIUS Venture Capital

SchwerinPre-Seed–Series A$540K – $1.6M

UBIJRFMS4 people

Aescap Life Sciences

AmsterdamSeed–Growth

PKPDBJGH14 people

DeepTech & Climate Fonds

MunichSeed–Late Stage$5.5M – $55M

RSAPSS3 people

Fresenius Medical Care Ventures

Bad HomburgSeed–Late Stage

AWAWASBH8 people

Vesalius Biocapital III Partners SàRL

ConternSeed–Late Stage$10.8M

CSGGMLCW12 people

YZR Capital

MunichPre-Seed–Growth

MFPDDMHE6 people

Sirius Venture Partners GmbH

WiesbadenSeed–Growth$540K – $5.4M

FVMBASJS8 people

YZR Capital

MunichPre-Seed–Growth

MFRMHEMS11 people

Linden Capital

ChicagoPre-Seed–Series A

M ACCELERATOR

Los AngelesGrowth$1M – $5M

AMSHACAP6 people

Nordic Capital

CopenhagenGrowth–Late Stage

KMCHHJJS7 people

Tauros Capital

ViennaSeries A–Growth$2.2M

BPCNMW3 people

EDB Investments

SingaporeSeed–Late Stage$12M – $400M

CKCLCGJO11 people

P53 Invest

StavangerSeed–Series A

SSLMKSØS5 people

Catalpa Ventures

GrevenmacherPre-Seed–Series A$330K – $1.6M

CGNWSRTG5 people

Target Partners

MunichSeed–Late Stage$1.1M – $3.2M

BVKMKMWJ10 people

Castel Capital

PaphosSeed–Growth$100K – $1M

ACJHMLPV4 people

Rosetta Capital Ltd.

OxfordSeries A–Late Stage

JHKMMFDL7 people

HTGF

BonnPre-Seed–Series A$1.1M

RSAVDA3 people

Ventura BioMed Investors

MunichSeed–Series A$1.1M – $5.5M

AJKR2 people

NGN Capital

New YorkSeries A–Late Stage

JCKAPJKJ6 people

Data sourced from public filings and firms' own websites — see our methodology.